Not Signed In -
Caffeine Addiction |
|
|
Clinical Trial: Piracetam for Treatment of Cocaine Addiction, Phase II - 4
This study has been completed.
Purpose
The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Piracetam | Phase I |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Piracetam for Treatment of Cocaine Addiction, Phase II
Eligibility
Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania, 19104 6178, United States
Study chairs or principal investigators
Kyle Kampman, M.D., Principal Investigator, University of Pennsylvania
More Information
Study ID Numbers: NIDA-00238-4; K02-00238-4
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000199
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000199
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Caffeine Addiction (HealthWorld)
- Caffeine Free (HealthWorld)
email this page
print this page
bookmark this page
feedback on this page
